targeted secretion inhibitors (Syntaxin)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Nametargeted secretion inhibitors (Syntaxin)
Drug Alias Nameclostridial endopeptidase-based compounds (Allergan)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Protein drugs > Toxin
Mechanisms of ActionEndopeptidases modulators
TargetsEndopeptidases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen BioInnovation Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen BioInnovation Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A